… study, we sought to perform a retrospective multicenter clinical analysis that compares the
efficacy, safety, and acquired resistance of first-line afatinib or erlotinib … gefitinib or erlotinib as …

… This study adopted a retrospective design with convenience sampling. Information on the
diagnosis, treatment, and follow-up of patients was uniformly collected from medical records …

… -interventional, multicenter, retrospective cohort study, based … it exerts higher activity than
erlotinib or gefitinib, albeit some … -generation inhibitors, including erlotinib and gefitinib, and is …

… to gefitinib or erlotinib. The median PFS was 8.0 months (95% CI: 4.9–9.5 months). Our …
single-center retrospective study with a small sample size. Prospective multicenter studies with a …

… We performed a retrospective study analyzing patients with advanced non-SCLC (NSCLC)
from eight sites who were diagnosed with SCLC transformation after receiving epidermal …

… We retrospectively collected and analyzed the data of patients who had been confirmed …
Of these patients, 36 received first-generation TKIs (16 gefitinib, 14 icotinib and 6 erlotinib) …

… , observational, multicenter study in West Denmark … A total of 76 patients were included in
this retrospective study from a … associated with sensitivity of tumors to gefitinib and erlotinib …

… 0901 trial that enrolled Chinese patients was designed to compare erlotinib and gefitinib, …
A retrospective study using population-based claims data between 2011 and 2015 showed …

… There are currently some ongoing studies investigating the efficacy of erlotinib, gefitinib, and
afatinib in patients with advanced NSCLC in some of the major medical centers in Vietnam; …

… as opposed to first-generation gefitinib and erlotinib, when efficacy and … study was the
retrospective nature of this study; however, from the literature, this study is the biggest cohort study …